Google
 
Google

World Stem Cell Summit 2010

Thursday, January 31, 2008

Nature Clinical Practice Oncology - Table of Contents alert Volume 5 Issue 2

NATURE CLINICAL PRACTICE ONCOLOGY

February 2008 Volume 5 Number 2

Visit Nature Clinical Practice Oncology online to browse the journal.

Now available at http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0UgF0Eo

=====================================================================

Access the #1 journal in Dermatology*

The Journal of Investigative Dermatology features timely, peer-reviewed
contributions highlighting experimental, theoretical, and clinical aspects
in cutaneous biology and skin disease. Recommend a site license to your
librarian by visiting

http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0BSup0Eo
and gain access to the leading journal in dermatology.

*Rank 1/39 Dermatology, Journal Citation Reports, Thomson, 2007

=====================================================================

----------------------
EDITORIAL
----------------------
Health insurance reform-beware of the general solution for the specific
problem
Vincent T DeVita Jr
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmej0Es

----------------------
VIEWPOINTS
----------------------
Screening for breast cancer: is it globally applicable?
Indraneel Mittra
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmek0Et

Are women with breast cancer receiving sufficient education and
information about their treatment?
Yvonne Wengstrom
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmel0Eu

----------------------
RESEARCH HIGHLIGHTS
----------------------
Identifying factors associated with increased mortality risk in stage I
NSCLC
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmem0Ev

Radiotherapy increases risk of secondary cancer in patients with cervical
cancer
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmen0Ew

Plasma HER2 and EGFR levels are prognostic factors in patients with
prostate cancer
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmeo0Ex

Radiofrequency ablation increases survival in colorectal cancer with
liver metastases
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmep0Ey

Prostatectomy confers the best chance of long-term prostate-cancer-specific
survival
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmeq0Ez

Preoperative radiotherapy reduces risk of local recurrence after total
mesorectal excision
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmer0E1

Abnormal p53 expression is a prognostic factor in locally advanced
prostate cancer
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmes0E2

Combined HPV and Pap testing is a potentially beneficial screening approach
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmet0E3

Complete estrogen blockade in advanced postmenopausal receptor-positive
breast cancer
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmeu0E4

Patients who survive 10 years after resection of colorectal liver
metastases are cured
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmev0E5

Level of HER2 amplification correlates with response to trastuzumab-based
therapy
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmew0E6

Study identifies 10-gene signature prognostic for survival in stage I
lung adenocarcinoma
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmex0E7

Upgrading Gleason score 7 and tertiary grade 5 prostate cancer is warranted
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmey0E8

Combined therapy improves survival in advanced-stage endometrial cancer
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bmez0EA

----------------------
PRACTICE POINTS
----------------------
Is double autologous stem-cell transplantation appropriate for new multiple
myeloma patients?
Frits van Rhee
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bme10Ev

Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin
an option for stage II and III colon cancer?
Chris Twelves
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bme20Ew

What effect does androgen suppression therapy have on frequency and
timing of fatal myocardial infarctions?
Jeffrey M Holzbeierlein
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bme30Ex

Switching to anastrozole after tamoxifen improves survival in
postmenopausal women with breast cancer
Francesco Boccardo
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bme40Ey

----------------------
REVIEWS
----------------------
Gonadal failure after treatment of hematologic malignancies: from
recognition to management for health-care providers
Kazutaka Nakayama, Andrea Milbourne, Leslie R Schover, Richard E Champlin
and Naoto T Ueno
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bme50Ez

The etiology and management of intractable breathlessness in patients
with advanced cancer: a systematic review of pharmacological therapy
Sara Booth, Shakeeb H Moosavi and Irene J Higginson
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bme60E1

Drug Insight: gastrointestinal stromal tumors (GIST)-the solid tumor
model for cancer-specific treatment
Stefan Sleijfer, Erik Wiemer and Jaap Verweij
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bme70E2

----------------------
CASE STUDY
----------------------
Improved outcome with multimodality therapy in primary cardiac angiosarcoma
Courtney Pigott, Michael Welker, Pam Khosla and Robert SD Higgins
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Bme80E3

=====================================================================

TOP TEN ONCOLOGY ARTICLES

NEW! View the ten most popular articles from last month's issue
of Nature Clinical Practice Oncology.

Articles are ranked according to the number of times they have
been downloaded.

http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0BmfA0EE


=====================================================================

You have been sent this Table of Contents Alert because you have opted
in to receive it. You can change or discontinue your e-mail alerts at
any time, by modifying your preferences on your nature.com account at:
http://ealerts.nature.com/cgi-bin24/DM/y/eiv70Xztnp0HjM0Zzu0Ez
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department:
registration@nature.com

For print subscription enquiries, please contact our subscription department:
subscriptions@nature.com

For other enquiries, please contact our customer feedback department:
feedback@nature.com

Nature Publishing Group | 75 Varick Street, 9th Floor | New York |
NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne -
San Diego - San Francisco - Washington - New York - Boston

=====================================================================

Google

Any Comments ?.......

E-mail: manojhind2001us@gmail.com
Google
 

World Time